Loading organizations...
Loading organizations...
Key people at Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals was founded by George D. Yancopoulos (President, Chief Scientific Office & co-Founder) and Leonard S. Schleifer (Founder, President, and Chief Executive Officer).
Regeneron Pharmaceuticals was founded by George D. Yancopoulos (President, Chief Scientific Office & co-Founder) and Leonard S. Schleifer (Founder, President, and Chief Executive Officer).
Key people at Regeneron Pharmaceuticals.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 17, 2022 | Vyriad | $29.5M Series B | Harry Stine | Mayo Clinic, Mirae Asset, Southeast Minnesota Capital Fund |
| Jun 1, 2020 | DNAnexus | $100.0M Series G | Northpond Ventures, Sam Chawla | aMoon Fund, Anorak Ventures, Baseline Ventures, Echo Health Ventures, First Round Capital, Foresite Capital, GV, Khosla Ventures, Kleiner Perkins, Lemnos Labs, venBio, Yumin Choi, TPG |
| Oct 2, 2019 | Adicet Bio, Inc | $80.0M Series B | — | Consensus Business Group, DSC Investment, Handok, Johnson & Johnson Innovation, KB Investment, Novartis, OCI Enterprises, OrbiMed, Pontifax, Samsung, SBI JI Innovation Fund |
| Jun 1, 2018 | Decibel Therapeutics | $55.0M Series C | — | Apollo Health Ventures, GV, LearnLaunch Accelerator, Qiming Venture Partners USA, The Column Group, Versant Ventures, Wayne Chang, Bessemer Trust, Foresite Capital, Longevity Venture Partners, Schroder Adveq, S-Cubed Capital, SR One, Third Rock Ventures |